Yi Zeng
- Otorhinolaryngology top 1%
- Cancer Research top 5%
- MicroRNA in disease regulation 7
- Cancer-related molecular mechanisms research 7
- Oncology top 5%
- Viral-associated cancers and disorders 15
- Virology top 5%
- HIV Research and Treatment 17
- Biomaterials top 5%
-
- HIV/AIDS drug development and treatment 9
-
- RNA Interference and Gene Delivery 5
- Advanced biosensing and bioanalysis techniques 5
-
- Cytomegalovirus and herpesvirus research 5
- Co-authors
- Guy de ThéCheryl A. WinklerHong‐Wen DengJian LiaoXiuchan GuoLi GuanMinzhong TangStephen J. O’Brien
- Partner nations
- ChinaUnited StatesFrance
In The Last Decade
Yi Zeng
76 papers receiving 2.9k citations
Hit Papers
Peers
Comparison fields: 5 of 149
- Otorhinolaryngology 276
- Cancer Research 594
- Oncology 863
- Virology 125
- Biomaterials 283
Countries citing papers authored by Yi Zeng
This map shows the geographic impact of Yi Zeng's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yi Zeng with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yi Zeng more than expected).
Fields of papers citing papers by Yi Zeng
This network shows the impact of papers produced by Yi Zeng. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yi Zeng. The network helps show where Yi Zeng may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Yi Zeng, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 4 | |
| 2 | 2018 | 11 | |
| 3 | 2018 | 2 | |
| 4 | 2016 | 6 | |
| 5 | 2016 | 20 | |
| 6 | 2016 | 28 | |
| 7 | 2015 | 5 | |
| 8 | 2015 | 7 | |
| 9 | 2014 | 12 | |
| 10 | Hyaluronic acid-chitosan nanoparticles for co-delivery of MiR-34a and doxorubicin in therapy against triple negative breast cancerbreakdown → | 2014 | 443 |
| 11 | 2013 | 74 | |
| 12 | 2013 | 21 | |
| 13 | 2013 | 29 | |
| 14 | 2013 | 12 | |
| 15 | 2011 | 12 | |
| 16 | [Genetic characteristics of HIV-1 CRF01_AE strains circulating in Beijing]. | 2010 | 1 |
| 17 | 2010 | 31 | |
| 18 | 2008 | 32 | |
| 19 | 2006 | 176 | |
| 20 | 2005 | 1 |
About Yi Zeng
Yi Zeng is a scholar working on Virology, Cancer Research and Oncology, having authored 78 papers that have together received 2.9k indexed citations. Recurring topics across this work include HIV Research and Treatment (17 papers), Viral-associated cancers and disorders (15 papers), HIV/AIDS drug development and treatment (9 papers), MicroRNA in disease regulation (7 papers), Cancer-related molecular mechanisms research (7 papers), RNA Interference and Gene Delivery (5 papers), Advanced biosensing and bioanalysis techniques (5 papers) and Cytomegalovirus and herpesvirus research (5 papers). The work is most often cited by research in Otorhinolaryngology (276 citations), Cancer Research (594 citations) and Oncology (863 citations). Yi Zeng has collaborated with scholars based in China, United States and France. Frequent co-authors include Guy de Thé, Cheryl A. Winkler, Hong‐Wen Deng, Jian Liao, Xiuchan Guo, Li Guan, Minzhong Tang, Stephen J. O’Brien, Wang Sheng and Ji Li. Their work appears in journals such as PLoS ONE, Biomaterials and Chemical Communications.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.